[1] Röllig C, Knop S, Bornhäuser M.Multiple myeloma[J]. Lancet, 2015, 385(9983): 2197-2208. [2] Kumar SK, Dispenzieri A, Lacy MQ, et al.Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients[J]. Leukemia, 2014, 28(5): 1122-1128. [3] Firth J.Haematology: multiple myeloma[J]. Clinical medicine, 2019, 19(1): 58-60. [4] Rajkumar SV.Multiple myeloma: 2020 update on diagnosis, risk-stratification and management[J]. American journal of hematology, 2020, 95(5): 548-567. [5] Hillengass J, Usmani S, Rajkumar SV, et al.International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders[J]. The Lancet Oncology, 2019, 20(6): e302-e312. [6] Schmidt T, Callander N.Diagnosis and Management of Monoclonal Gammopathy and Smoldering Multiple Myeloma[J]. Journal of the National Comprehensive Cancer Network : JNCCN, 2020, 18(12): 1720-1729. [7] Shao T, Wang G, Chen H, et al.Survey of miRNA-miRNA cooperative regulation principles across cancer types[J]. Briefings in bioinformatics, 2019, 20(5): 1621-1638. [8] van de Donk N, Pawlyn C, Yong KL. Multiple myeloma[J]. Lancet, 2021, 397(10272): 410-427. [9] Barwick BG, Gupta VA, Vertino PM, et al.Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma[J]. Frontiers in immunology, 2019, 10: 1121. [10] Neuse CJ, Lomas OC, Schliemann C, et al.Genome instability in multiple myeloma[J]. Leukemia, 2020, 34(11): 2887-2897. [11] Mori MA, Ludwig RG, Garcia-Martin R, et al.Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease[J]. Cell metabolism, 2019, 30(4): 656-673. [12] Williams Z, Ben-Dov IZ, Elias R, et al.Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations[J]. Proc Natl Acad Sci U S A, 2013, 110(11): 4255-4260. [13] Ishii H, Kaneko S, Yanai K, et al.MicroRNA Expression Profiling in Diabetic Kidney Disease[J]. Translational research, 2021, 237: 31-52. [14] Zhou L, Wang W, Wang F, et al.Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma[J]. Molecular cancer, 2021, 20(1): 57. [15] Moya L, Meijer J, Schubert S, et al.Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis[J]. International journal of molecular sciences, 2019, 20(5). [16] Cheng X, Ander BP, Jickling GC, et al.MicroRNA and their target mRNAs change expression in whole blood of patients after intracerebral hemorrhage[J]. Journal of cerebral blood flow and metabolism, 2020, 40(4): 775-786. [17] Karabegović I, Abozaid Y, Maas SCE, et al.Plasma MicroRNA Signature of Alcohol Consumption: The Rotterdam Study[J]. The Journal of nutrition, 2023, 152(12): 2677-2688. [18] 中国医师协会血液科医师分会,中华医学会血液学分会. 中国多发性骨髓瘤诊治指南(2022年修订)[J]. 中华内科杂志, 2022,61(5):480-487. [19] Kumar SK, Rajkumar V, Kyle RA, et al.Multiple myeloma[J]. Nature reviews Disease primers, 2017, 3: 17046. |